LAM
BMY icon

LECAP Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

LECAP Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,951
Closed -$483K – 284
2025
Q4 		$483K Buy
8,951
+1,583
+21% +$76.2K 0.19% 192
2025
Q3 		$332K Sell
7,368
-19,756
-73% -$923K 0.12% 240
2025
Q2 		$1.26M Buy
+27,124
New +$1.33M 0.44% 79
2025
Q1 		– Sell
-33,177
Closed -$1.88M – 294
2024
Q4 		$1.88M Sell
33,177
-12,891
-28% -$720K 0.51% 65
2024
Q3 		$2.38M Sell
46,068
-10,719
-19% -$503K 0.51% 61
2024
Q2 		$2.36M Buy
56,787
+15,036
+36% +$673K 0.51% 61
2024
Q1 		$2.26M Buy
41,751
+14,572
+54% +$742K 0.47% 69
2023
Q4 		$1.39M Buy
+27,179
New +$1.43M 0.51% 60

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LECAP Asset Management's BMY Position: Q1 2026 in Review

LECAP Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 8,951 shares — an estimated $483K sold.

LECAP Asset Management first reported a position in BMY in Q4 2023 and held it in 8 quarters. The position peaked at $2.38M in Q3 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LECAP Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • LECAP Asset Management sold 8,951 Bristol-Myers Squibb shares in Q1 2026, an estimated $483K.
  • LECAP Asset Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 8 quarters.
  • LECAP Asset Management's Bristol-Myers Squibb position peaked at $2.38M in Q3 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.